Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Sun, 24 Jun 18 01:09:31 +0000 Sun, 24 Jun 18 01:09:31 +0000 Pharmacist and Physician Collaboration Gives Physicians More Freedom http://www.pharmacytimes.com/news/pharmacist-and-physician-collaboration-gives-physicians-more-freedom http://www.pharmacytimes.com/news/pharmacist-and-physician-collaboration-gives-physicians-more-freedom Thu, 21 Jun 18 19:54:00 +0000 Multimed Packaging Shown to Improve Medication Adherence http://www.pharmacytimes.com/news/multimed-packaging-shown-to-improve-medication-adherence http://www.pharmacytimes.com/news/multimed-packaging-shown-to-improve-medication-adherence An improvement in clinical outcomes and medication adherence rates when patients used medication therapy management services and multimed blister card packaging was clearly shown in a recent study. Thu, 21 Jun 18 19:32:00 +0000 What Advice Can You Give Independent Pharmacists to Succeed in their Industry? http://www.pharmacytimes.com/news/what-advice-can-you-give-independent-pharmacists-to-succeed-in-their-industry- http://www.pharmacytimes.com/news/what-advice-can-you-give-independent-pharmacists-to-succeed-in-their-industry- Wed, 20 Jun 18 14:45:00 +0000 What Resources are Available for Independent Pharmacies? http://www.pharmacytimes.com/news/what-resources-are-available-for-independent-pharmacies- http://www.pharmacytimes.com/news/what-resources-are-available-for-independent-pharmacies- Tue, 19 Jun 18 19:30:00 +0000 What Pharmacy Students Need to Learn about Independent Pharmacies http://www.pharmacytimes.com/news/what-pharmacy-students-need-to-learn-about-independent-pharmacies http://www.pharmacytimes.com/news/what-pharmacy-students-need-to-learn-about-independent-pharmacies Tue, 19 Jun 18 13:52:00 +0000 What Challenges Do Independent Pharmacists Face Today? http://www.pharmacytimes.com/news/what-challenges-do-independent-pharmacists-face-today http://www.pharmacytimes.com/news/what-challenges-do-independent-pharmacists-face-today Mon, 18 Jun 18 19:58:00 +0000 What Management Options are Available for Independent Pharmacists? http://www.pharmacytimes.com/news/how-do-you-help-independent-pharmacists-overcome-challenges-at-mckesson http://www.pharmacytimes.com/news/how-do-you-help-independent-pharmacists-overcome-challenges-at-mckesson Mon, 18 Jun 18 15:49:00 +0000 FDA Approves First Generic of Drug Used to Treat Opioid Dependence http://www.pharmacytimes.com/news/fda-approves-first-generic-of-drug-used-to-treat-opioid-dependence http://www.pharmacytimes.com/news/fda-approves-first-generic-of-drug-used-to-treat-opioid-dependence Agency officials have given the green light to versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy&#39;s Laboratories SA) sublingual film. Thu, 14 Jun 18 21:22:00 +0000 Bevacizumab with Chemotherapy Approved by FDA for Ovarian Cancer http://www.pharmacytimes.com/news/bevacizumab-with-chemotherapy-approved-by-fda-for-ovarian-cancer http://www.pharmacytimes.com/news/bevacizumab-with-chemotherapy-approved-by-fda-for-ovarian-cancer Officials with the FDA have approved bevacizumab (Avastin, Genentech) for patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer in combination with carboplatin and paclitaxel. Wed, 13 Jun 18 19:32:00 +0000 Pharmacist-Physician Collaborations Shown to be Mutually Beneficial http://www.pharmacytimes.com/news/pharmacistphysician-collaborations-shown-to-be-mutually-beneficial http://www.pharmacytimes.com/news/pharmacistphysician-collaborations-shown-to-be-mutually-beneficial At the American Pharmacy Purchasing Alliance&rsquo;s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work. &nbsp; Mon, 11 Jun 18 11:34:00 +0000 Panel: Independent Pharmacies Need Changes to PBM Relationship http://www.pharmacytimes.com/news/panel-independent-pharmacies-need-changes-to-pbm-relationship http://www.pharmacytimes.com/news/panel-independent-pharmacies-need-changes-to-pbm-relationship Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL. Sat, 09 Jun 18 11:55:00 +0000 5 Ways Pharmacists Can Help Prevent Suicide http://www.pharmacytimes.com/news/5-ways-pharmacists-can-help-prevent-suicide http://www.pharmacytimes.com/news/5-ways-pharmacists-can-help-prevent-suicide The deaths this week of Kate Spade and&nbsp;Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented. Fri, 08 Jun 18 18:00:00 +0000 Parata Systems and Pharmacy Times Announce Judges for 2018 Next-Generation Pharmacist Awards http://www.pharmacytimes.com/news/parata-systems-and-pharmacy-times-announce-judges-for-2018-nextgeneration-pharmacist-awards http://www.pharmacytimes.com/news/parata-systems-and-pharmacy-times-announce-judges-for-2018-nextgeneration-pharmacist-awards An esteemed panel will deliberate more than 600 nominations. Fri, 08 Jun 18 14:00:00 +0000 First Biosimilar to Pegfilgrastim Approved by FDA http://www.pharmacytimes.com/news/first-biosimilar-to-pegfilgrastim-approved-by-fda http://www.pharmacytimes.com/news/first-biosimilar-to-pegfilgrastim-approved-by-fda The FDA has approved pegfilgrastim-jmdb (Fulphila, Mylan GmbH) as the first biosimilar to pegfilgrastim (Neulasta) to help reduce the chance of fever-causing infection for a population of patients with cancer. Mon, 04 Jun 18 21:44:00 +0000 Combination Shows Promise for Treating Advanced Non Small Cell Lung Cancer http://www.pharmacytimes.com/news/combination-shows-promise-for-treating-advanced-non-small-cell-lung-cancer http://www.pharmacytimes.com/news/combination-shows-promise-for-treating-advanced-non-small-cell-lung-cancer Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non&ndash;small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.&nbsp; Mon, 04 Jun 18 15:53:00 +0000 FDA Approves Baricitinib for Moderate-to-Severe Rheumatoid Arthritis http://www.pharmacytimes.com/news/fda-approves-baricitinibfor-moderatetosevere-rheumatoid-arthritis http://www.pharmacytimes.com/news/fda-approves-baricitinibfor-moderatetosevere-rheumatoid-arthritis The FDA has approved baricitinib (Olumiant), a once-daily oral drug for adults with moderately-to-severely active rheumatoid arthritis. Sun, 03 Jun 18 18:39:00 +0000 FDA Announces New Policies to Help Promote Drug Competition and Access http://www.pharmacytimes.com/news/fda-announces-new-policies-to-help-promote-drug-competition-and-access http://www.pharmacytimes.com/news/fda-announces-new-policies-to-help-promote-drug-competition-and-access New policies that aim to help generic drug makers move their products through the development and approval processes more efficiently have been announced by FDA Commissioner Scott Gottlieb, MD. Thu, 31 May 18 20:13:00 +0000 Pharmacy Times and Specialty Pharmacy Times Receive the 2018 Hermes Creative Awards http://www.pharmacytimes.com/news/pharmacy-times-and-specialty-pharmacy-times-receive-the-2018-hermes-creative-awards http://www.pharmacytimes.com/news/pharmacy-times-and-specialty-pharmacy-times-receive-the-2018-hermes-creative-awards <em>Pharmacy Times</em>, the leading media resource for pharmacists and the pharmacy industry, and&nbsp;<em>Specialty Pharmacy Times</em>, the most read publication among specialty pharmacists, have been honored with the 2018 Hermes Creative Awards.&nbsp; Thu, 31 May 18 19:13:00 +0000 FDA OKs Treatment for Moderately to Severely Active Ulcerative Colitis http://www.pharmacytimes.com/news/fda-oks-treatment-for-moderately-to-severely-active-ulcerative-colitis- http://www.pharmacytimes.com/news/fda-oks-treatment-for-moderately-to-severely-active-ulcerative-colitis- Tofacitinib is the first and only Janus kinase inhibitor approved by the FDA for this patient population. Wed, 30 May 18 21:28:00 +0000 ACS Lowers Age for Colorectal Cancer Screening Guideline http://www.pharmacytimes.com/news/acs-lowers-age-for-colorectal-cancer-screening-guideline http://www.pharmacytimes.com/news/acs-lowers-age-for-colorectal-cancer-screening-guideline Screening for colorectal cancer (CRC) should begin at age 45 for people of average risk, according to newly updated American Cancer Society guidelines. Wed, 30 May 18 17:56:00 +0000 Oral Contraceptive Sample Packs Recalled http://www.pharmacytimes.com/news/oral-contraceptive-sample-packs-recalled http://www.pharmacytimes.com/news/oral-contraceptive-sample-packs-recalled One lot of TAYTULLA Softgel capsules sample packs (1 mg/20mcg, 6x28 size) has been voluntarily recalled by Allergan. Wed, 30 May 18 12:00:00 +0000 New Treatment for Phenylketonuria Approved by FDA http://www.pharmacytimes.com/news/new-treatment-for-phenylketonuria-approved-by-fda http://www.pharmacytimes.com/news/new-treatment-for-phenylketonuria-approved-by-fda Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency. Thu, 24 May 18 23:00:00 +0000 First Label Update to Include Data on Psoriasis Involving the Genital Area is Approved by FDA http://www.pharmacytimes.com/news/first-label-update-to-include-data-on-psoriasis-involving-the-genital-area-is-approved-by-fda http://www.pharmacytimes.com/news/first-label-update-to-include-data-on-psoriasis-involving-the-genital-area-is-approved-by-fda The FDA has approved an updated label for Eli Lilly&rsquo;s ixekizumab (Taltz) injection 80 mg/mL to include data in psoriasis involving the genital area. Wed, 23 May 18 23:00:00 +0000 Taking Action Against Skin Cancer and Misleading Labels http://www.pharmacytimes.com/news/taking-action-against-skin-cancer-and-misleading-ot http://www.pharmacytimes.com/news/taking-action-against-skin-cancer-and-misleading-ot The FDA is taking new steps to ensure products being marketed to protect consumers from the sun&rsquo;s harmful effects deliver on their promises, as it recognizes No Fry Day. Wed, 23 May 18 20:01:00 +0000 FDA Officials Issue Warning Letters to 3 Kratom Marketers http://www.pharmacytimes.com/news/fda-officials-issue-warning-letters-to-3-kratom-marketers http://www.pharmacytimes.com/news/fda-officials-issue-warning-letters-to-3-kratom-marketers Health care professionals and consumers are encouraged to report any adverse events related to these products to the FDA&rsquo;s&nbsp;MedWatch&nbsp;Adverse Event Reporting program. Wed, 23 May 18 01:55:00 +0000